Izraelis - hebrajų - Ministry of Health

david margalit & co.ltd - ciprofloxacin as hydrochloride 500 mg - tablets - fluoroquinolones - broad spectrum antibiotic for infections caused by ciprofloxacin sensitive pathogens: invasive infections of the external ear. treatment of acute pulmonary exacerbation of cystic fibrosis associated with p.aeroginosa infections in pediatric patients aged 5-17 years.

Izraelis - hebrajų - Ministry of Health

sanofi - aventis israel ltd - ofloxacin 200 mg - film coated tablets - ofloxacin - for the treatment of bacterial infections if these are due to ofloxacin sensitive pathogens.

Izraelis - hebrajų - Ministry of Health

sanofi - aventis israel ltd - ofloxacin 2 mg/ml - solution for infusion - ofloxacin - infections of kidney, urinarty tract, genital organs, respiratory tract, chronic and recurrent ear, nose and throat, skin and soft tissues, bones and joints, bacterial enteritis, abdominal cavity, including pelvis minor and septicemia caused by ofloxacin sensitive microorganisms. prevention of infections in patients with a signifcant reduction of resistance to infections,

Izraelis - hebrajų - Ministry of Health

abic ltd. - ofloxacin - טבליה - ofloxacin 200 mg - ofloxacin - ofloxacin - bacterial infections due to ofloxacin-susceptible microorganisms, such as:- acute, chronic, or recurrent lower respiratory tract infections (bronchitis) pneumonia (not for the treatment of first choice in pnemonia caused by pneumococci). - chronic and recurrent infections of the ear, nose, and throat. ofloxacin is in general not indicated for the treatment of acute tonsillitis caused by betahaemolytic streptococci. - infections of soft tissues and skin. - infections of the bones and joints. - abdominal infections including infections in the pelvis minor and bacterial enteritis. - infections of the kidney, urinary tract, and genital organs, gonorrhoea.prevention of infections due to ofloxacin-susceptible pathogens in patients with a significant reduction in resistance to infections (e.g. in neutropenic state).

Izraelis - hebrajų - Ministry of Health

dexcel ltd, israel - ofloxacin - קפליות - ofloxacin 200 mg - ofloxacin - ofloxacin - bacterial infections due to ofloxacin-susceptible microorganisms, such as: upper and lower urinary tract infections, lower respiratory tract infections uncomplicated urethral and cervical gonorrhoea, non-gonococcal urethritis and cervicitis, skin and soft tissue infections.

Izraelis - hebrajų - Ministry of Health

bioavenir ltd, israel - ofloxacin as hydrochloride - תמיסה לאינפוזיה - ofloxacin as hydrochloride 2 mg/ml - ofloxacin - ofloxacin - infections of kidney, urinarty tract, genital organs, respiratory tract, chronic and recurrent ear, nose and throat, skin and soft tissues, bones and joints, bacterial enteritis, abdominal cavity, including pelvis minor and septicemia caused by ofloxacin sensitive microorganisms. prevention of infections in patients with a signifcant reduction of resistance to infections.

Izraelis - hebrajų - Ministry of Health

bayer israel ltd - ciprofloxacin as lactate 0.2 g / 100 ml - solution for infusion - ciprofloxacin - adults:uncomplicated and complicated infections caused by ciprofloxacin sensitive pathogens.children: for the treatment of acute pulmonary exacerbation of cystic fibrosis associated with pseudomonas aeroginosa infections in pediatric patients aged 5-17 years.

Izraelis - hebrajų - Ministry of Health

dexcel ltd, israel - ciprofloxacin as hydrochloride - טבליה - ciprofloxacin as hydrochloride 250 mg - ciprofloxacin - ciprofloxacin - broad spectrum antibiotic for infections caused by ciprofloxacin sensitive pathogens: invasive infections of the external ear. treatment of acute pulmonary exacerbation of cystic fibrosis associated with p. aeruginosa infections in pediatric patients aged 5-17 years.

Izraelis - hebrajų - Ministry of Health

dexcel ltd, israel - ciprofloxacin as hydrochloride - קפליות - ciprofloxacin as hydrochloride 500 mg - ciprofloxacin - ciprofloxacin - broad spectrum antibiotic for infections caused by ciprofloxacin sensitive pathogens: invasive infections of the external ear. treatment of acute pulmonary exacerbation of cystic fibrosis associated with p. aeruginosa infections in pediatric patients aged 5-17 years.

Izraelis - hebrajų - Ministry of Health

dexcel ltd, israel - ciprofloxacin as hydrochloride - קפליות - ciprofloxacin as hydrochloride 750 mg - ciprofloxacin - ciprofloxacin - broad spectrum antibiotic for infections caused by ciprofloxacin sensitive pathogens: invasive infections of the external ear. treatment of acute pulmonary exacerbation of cystic fibrosis associated with p. aeruginosa infections in pediatric patients aged 5-17 years.